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ABSTRACT
Brassinosteroids (BRs) are a unique class of plant
steroids that are structurally similar to animal ster-
oid hormones and play important roles in plant
growth and development. Unlike the animal ster-
oids, which bind to classical intracellular steroid
receptors that directly modulate gene activities after
translocation into the nucleus, the plant steroids
rely on transmembrane receptor kinases to activate
a phosphorylation cascade to regulate gene expres-
sion. Recent genetic and biochemical studies have
identified several critical BR signaling components
and revealed a striking mechanistic similarity be-
tween the plant steroid signaling pathway and
several well-studied animal signaling cascades in-
volving a receptor kinase and glycogen synthase
kinase 3 (GSK3). A working model for BR signal
transduction proposes that BR initiates its signaling
pathway by promoting heterodimerization of two
transmembrane receptor-like kinases at the cell
surface, leading to inhibition of a GSK3 kinase and
subsequent stabilization and nuclear accumulation
of two GSK3 substrates that regulate BR-responsive
genes. Such a simple model provides a framework
for continued investigation of molecular mecha-
nism(s) of plant steroid signaling.
Key words: Arabidopsis; Brassinosteroid; GSK3;
Leucine-rich-repeat receptor-like kinase; Receptor
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INTRODUCTION
Brassinosteroids (BRs) are a unique class of plant
polyhydroxysteroids that are structurally similar to
the well-studied animal and insect steroids. When
applied exogenously to plants, BRs affect a variety
of physiological processes, including cell division,
cell elongation, vascular differentiation, root growth
inhibition, biotic and abiotic stress tolerance, re-
productive development, and modulation of gene
expression (Clouse and Sasse 1998). The essential
function of endogenous BRs was revealed by dra-
matic morphological changes of mutants that are
defective in BR biosynthesis in several plant species
including Arabidopsis, pea, rice, and tomato (Hong
and others 2002; Mori and others 2002; Fujioka and
Yokota 2003). In Arabidopsis, BR-deficient mutants
display a characteristic mutant phenotype, includ-
ing a dwarf stature with dark green and rounded
rosette leaves, delayed flowering and senescence,
reduced apical dominance and male fertility, altered
vascular structure and cytoskeleton organization,
and abnormal skotomorphogenesis in the dark (Li
and others 1996; Szekeres and others 1996). All of
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these growth defects can be suppressed by supplying
BRs to the growth medium.
In animals, steroid hormone signaling is initiated
mainly by intracellular steroid receptors that belong
to a large family of structurally related nuclear re-
ceptors with a characteristic three-domain structure
consisting of an N-terminal transcriptional activa-
tion domain, a middle DNA-binding domain, and a
C-terminal ligand-binding/protein dimerization do-
main (Aranda and Pascual 2001). In the absence of
steroids, these intracellular steroid receptors are
locked into nonproductive forms by association
with heat shock proteins and other chaperones.
Upon steroid binding, the receptors dissociate from
the heat shock protein complexes, move into the
nucleus, and bind to regulatory DNA sequences of
their target genes to either activate or repress gene
expression, leading to various physiological and
developmental changes. Alternatively, animal ster-
oid signaling can be rapidly activated at the cell
surface by the membrane-localized steroid receptors
to induce the so-called ‘‘nongenomic’’ steroid ef-
fects on cell physiology independent of gene regu-
lation (Losel and Wehling 2003). Candidates for
such membrane steroid receptors include the
membrane-associated classical steroid receptors
(Shaul 2002), G-protein coupled receptors (GPCRs,
Grazzini and others 1998), and a novel family of
membrane steroid-binding proteins that are struc-
turally similar to GPCRs (Hammes 2003). It is
known that calcium, cAMP, heterotrimeric G pro-
teins, and protein phosphorylation are involved in
the membrane-initiated steroid signaling pathways
(Cato and others 2002).
By contrast, plants seem to lack the classical
steroid signaling pathway, and the completely se-
quenced Arabidopsis genome does not encode any
protein that shows significant sequence homology
to the highly conserved nuclear steroid receptors
(Arabidopsis Genome Initiative 2000). Instead,
plant steroids are mainly, if not exclusively, recog-
nized by cell surface receptors to initiate their
signaling pathways to regulate a variety of physio-
logical processes (Li 2003). Recent advances in the
study of BR signaling have dramatically increased
our understanding of how the plant steroid signal is
perceived on the cell surface, transmitted into the
cytosol, and finally transduced into the nucleus to
regulate gene activities (Clouse 2002a, 2002b). This
review highlights the characterization of several
Arabidopsis proteins that are believed to be involved
in plant steroid perception and signal transduction.
Biochemical and genetic studies of these BR signa-
ling components are beginning to reveal the mode
of steroid action in plants.
BRI1: A CRITICAL COMPONENT
OF A MEMBRANE BR RECEPTOR
BRI1 (Brassinosteroid-Insensitive 1), the first
known component of the plant steroid signaling
pathway, was initially discovered in a genetic screen
for Arabidopsis mutants that showed normal root
growth in the presence of high concentrations of BR
(Clouse and others 1996). Repeated genetic screens
for loss-of-function BR-insensitive mutants only
resulted in the identification of additional bri1 al-
leles, indicating that BRI1 is an essential nonre-
dundant component of the plant steroid signaling
pathway (Kauschmann and others 1996; Li and
Chory 1997; Noguchi and others 1999; Friedrichsen
and others 2000). bri1 mutants are morphologically
indistinguishable from BR-deficient dwarf mutants
but cannot be rescued by exogenous BR application
(Kauschmann and others 1996; Li and Chory 1997).
Interestingly, these mutants also accumulate high
levels of brassinolide (BL), the most active BR, and
its biosynthetic precursors, with the more severe
bri1 mutants accumulating higher levels of endog-
enous BRs, suggesting that BRI1 plays an important
role in regulating BR homeostasis (Noguchi and
others 1999). It was reported that BR insensitivity in
bri1 mutants was also observed at the molecular
level (Kauschmann and others 1996). The BR-in-
duced expression of two xyloglucan endotransgly-
cosylase genes, TCH4 and meri5, was absent in bri1-2
mutants, although the GA-induced meri5 expression
was still observed. Taken together, these genetic and
physiological studies strongly suggest that BRI1 en-
codes an essential component of the plant steroid
signaling pathway.
The BRI1 gene was cloned by a map-based strat-
egy and was found to encode a leucine-rich-repeat
receptor-like kinase (LRR–RLK) that consists of an
LRR-containing extracellular domain, a single
transmembrane segment, and a cytoplasmic Ser/Thr
kinase domain (Figure 1) (Li and Chory 1997). The
extracellular domain is composed of several discrete
regions, including an N-terminal signal peptide, a
leucine-zipper motif that might mediate protein–
protein interaction, and two pairs of cysteine resi-
dues flanking 25 tandem LRRs that are disrupted by
a 70 amino acid (70AA) island domain between the
21st and 22nd LRRs (Figure 1). Analyses of various
bri1 mutant alleles identified several regions essen-
tial for in vivo BRI1 function (Figure 1) (Li and
Chory 1997; Noguchi and others 1999; Friedrichsen
and others 2000). The bri1-5 mutant contains a
Cys69Tyr substitution in the first cysteine pair that
might be important for mediating disulfide-linked
dimerization of BRI1 with itself or its action part-
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ners, while the bri1-9 mutant harbors a Ser662Phe
missense mutation in the 22nd LRR that is imme-
diately downstream from the 70AA island. The bri1-
102 mutation changes Thr750 to Ile, which is lo-
cated between the last LRR and the second cysteine
pair. Five mutations were identified in the 70AA
island domain, including two nonsense (bri1-114
and bri1-116) and three missense mutations (bri1-6/
bri1-119, bri1-7, and bri1-113), each involving a
change of a glycine residue. The clustering of mu-
tations in this domain led to a hypothesis that the
70AA island might be directly or indirectly involved
in binding the plant steroids. As expected from its
similarity with animal RLKs, allele sequencing also
confirmed the essential role of the kinase domain
for transmitting BR signals. Among 28 bri1 alleles
sequenced to date, 15 alleles contain mutations in
the kinase domain (Li and Chory 1997; Noguchi
and others 1999; Friedrichsen and others 2000).
These kinase mutations might affect receptor
dimerization, recruitment of downstream signaling
proteins, or the catalytic activity of the kinase do-
main, thus blocking the propagation of BR signa-
ling.
The deduced BRI1 protein sequence predicts that
BRI1 spans across the cell membrane. Although
there is no immunohistochemical data to prove this
prediction and to determine the topology of the
BRI1 protein, confocal microscopic analysis of a
BRI1:GFP fusion protein revealed that BRI1 is lo-
calized at the plasma membrane (Friedrichsen and
others 2000). The BRI1 cytoplasmic domain is ex-
pected to contain serine/threonine kinase activity
that is essential for transmitting BR signal into the
cytosol. Biochemical analyses of an E. coli-expressed
calmodulin-binding peptide (CBP)–BRI1 kinase fu-
sion protein and a C-terminal HA-tagged full-length
BRI1 protein expressed in human cell cultures
confirmed that BRI1 is indeed a functional kinase in
vitro (Friedrichsen and others 2000; Oh and others
2000). Phosphoamino acid analyses revealed that
the in vitro autophosphorylated BRI1 protein con-
tains both phospho-Ser and phospho-Thr but no
phospho-Tyr (Friedrichsen and others 2000; Oh and
others 2000), thus proving that BRI1 belongs to the
serine/threonine kinase family. Matrix-assisted la-
ser desorption/ionization–mass spectrometry anal-
yses with an in vitro phosphorylated CBP–BRI1
kinase fusion protein identified at least 12 autop-
hosphorylation sites, including 5 in the juxtamem-
brane segment, 5 in the core kinase domain, and 2
in the carboxyl terminal region (Oh and others
2000). These phosphorylated residues may partici-
pate in regulating the kinase activity of the BRI1
protein or serve as docking sites to recruit different
downstream BR signaling proteins into an activated
Figure 1. Schematic structure of
BRI1 and BAK1 receptor kinases.
Both receptor kinases are made up of
similar structural domains and se-
quence motifs, but BAK1 is a much
smaller protein, containing only 5
LRRs and missing the 70AA island
domain and the second cysteine pair.
Asterisks represent known mutations
found in BRI1 and BAK1.
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BR receptor complex. Thus, BRI1 is a membrane-
associated receptor kinase that plays a key role in
BR signaling through Ser/Thr phosphorylation.
The importance of BRI1 in BR signaling was
further supported by the molecular genetic charac-
terization of BR-insensitive dwarf mutants in other
plant species. Two allelic rice dwarf mutants with
erect leaves, d61-1 and d61-2, were found to be less
sensitive to BR treatment and accumulated higher-
than-wild-type levels of BRs. Molecular cloning
experiments revealed that a Thr989Ile mutation in
the kinase domain and a Val491Met mutation in the
18th LRR of a rice BRI1 homologue were respon-
sible for the BR-insensitive dwarf phenotype of the
d61-1 and d61-2 mutants, respectively (Yamamuro
and others 2000). In pea, three BR-related dwarf
mutants were known (Nomura and others 1997,
1999; Schultz and others 2001), including two BR-
deficient mutants, lk and lkb, and a BR-insensitive
mutant, lka. It was reported that the lka mutant,
which is morphologically similar to lk and lkb mu-
tants but could not be rescued by exogenous BR
treatment, contains a missense mutation in a pea
BRI1 homologue (Normura and others 2001).
Similarly, two BR-insensitive tomato mutants, curl3
(Koka and others 2000) and abs1 (Montoya and
others 2002), were recently found to contain a
nonsense mutation and a missense mutation in the
extracellular domain and the kinase domain, re-
spectively, of a tomato BRI1 homologue, tBRI1
(Montoya and others 2002). Surprisingly, tBRI1 was
found to be identical to SR160, a putative mem-
brane receptor for a peptide hormone systemin in-
volved in wounding response (Scheer and Ryan
2002), suggesting that tBRI1 might be able to rec-
ognize two distinct ligands: a steroid and a peptide
(Szekeres 2003).
Although there is no direct demonstration that
purified BRI1 proteins can bind BL or its active
analogues, several lines of experimental evidence
support that BRI1 is crucial for a membrane BR
receptor activity. He and others (2000) provided
indirect evidence showing that BRI1’s extracellular
domain is involved in BR sensing. The extracellular
domain, the transmembrane a-helix, plus a small
intracellular juxtamembrane segment of the BRI1
protein were fused to the cytoplasmic kinase do-
main of Xa21, a rice LRR–RLK involved in disease
resistance (Song and others 1995), to generate a
BRI1:Xa21 chimeric receptor. Upon treatment with
BL, this chimeric receptor can initiate a typical plant
defense response in rice cell cultures, including
rapid cell death, oxidative burst, and the expression
of pathogenesis-related genes. Both the BRI1 por-
tion and the Xa21 kinase domain are necessary for
the activity of the BRI1:Xa21 chimeric receptor be-
cause a mutation in either domain completely
abolished the BR-activated defense responses. These
results clearly demonstrated the essential role of
BRI1’s extracellular domain, especially the 70AA
island, for BR binding. Further support for BRI1
being a membrane BR receptor came from several
BR-binding assays. Wang and others (2001) showed
that transgenic Arabidopsis plants overexpressing
BRI1 exhibited a higher BR sensitivity and con-
tained a higher BR binding activity in their mem-
brane fractions. Consistent with previous genetic
data, mutations in the extracellular domain elimi-
nated such a BR binding activity, whereas muta-
tions in the kinase domain had no effect on BR
binding. Importantly, such a BR binding activity can
be coimmunoprecipitated with BRI1. In line with
the hypothesis that BRI1 is a crucial element of a BR
receptor, BL treatment stimulated BRI1 autop-
hosphorylation in wild-type Arabidopsis seedlings
but not in bri1 mutants containing a kinase-dead
mutation. Based on these data, it was suggested that
BR binding, either directly or indirectly, to the
extracellular domain of BRI1, would activate the




It is well known that animal receptor kinases are
activated by ligand-induced homo- or heterodime-
rization. Thus, it would be reasonable to assume
that BRI1 is activated in a similar fashion by BR via
the formation of homo- or heterodimers. The latter
model is much more favored by the recent discovery
of BRI1-associated receptor kinase 1 (BAK1) as a
potential coreceptor for BRI1 (Li and others 2002;
Nam and Li 2002).
BAK1 was identified independently by a yeast
two-hybrid screen as a specific BRI1-interacting
protein (Nam and Li 2002) and by a gain-of-func-
tion activation-tagging screen as an extragenic
suppressor of bri1-5, a weak extracellular bri1 mu-
tation mentioned above (Noguchi and others 1999).
Like BRI1, BAK1 is also an LRR-containing receptor
kinase (Figure 1) and belongs to a small subfamily of
the Arabidopsis LRR–RLK (LRRII, Shiu and Bleecker
2001) that contains 13 other members including the
Arabidopsis SOMATIC EMBRYOGENESIS RECEP-
TOR kinase 1 (AtSERK1), which was known to
enhance somatic embryogenesis when overex-
pressed (Hecht and others 2001). However, BAK1
contains only 5 LRRs in its extracellular domain and
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lacks the 70AA island domain, a characteristic fea-
ture of BRI1 and its homologues. Northern blot
analysis revealed that BRI1 and BAK1 share similar
gene expression domains, and confocal microscopic
analysis of transgenic plants expressing a BAK1:GFP
fusion protein showed that BAK1 is also a mem-
brane-localized protein. Coimmunoprecipitation
experiments were performed to demonstrate that
BRI1 and BAK1 interact physically in yeast cells and
in plants (Li and others 2002; Nam and Li 2002).
These data strongly suggest that BAK1 and BRI1
have the potential to form a heterodimer at the cell
surface.
Genetic studies with both gain-of-function and
loss-of-function approaches showed that BAK1 is
also involved in BR signaling (Li and others 2002;
Nam and Li 2002). Overexpression of the BAK1
gene not only suppressed the bri1-5 mutation, but
also rescued, in a dose-dependent manner, the
mutant phenotype of bri1-301 containing a weak
kinase mutation, indicating that BAK1 becomes a
rate-limiting factor when the activity of BRI1 is re-
duced. In addition, BAK1 overexpression in a wild-
type background gave rise to a phenotype that was
previously observed in transgenic Arabidopsis plants
overexpressing BRI1 (Wang and others 2001) or
DWARF4 (DWF4) that encodes a P450 steroid hy-
droxylase catalyzing a rate-limiting step of BR bio-
synthesis (Choe and others 1998, 2001). In contrast,
two null bak1 mutations, caused by T-DNA inser-
tions in either the first exon or the third intron of
the BAK1 gene, resulted in a weak bri1-like phe-
notype with a semidwarf stature, a compact rosette,
shortened inflorescent stems, and reduced sensitiv-
ity to BR in inhibiting root elongation (Li and others
2002; Nam and Li 2002). The weak phenotype of
the two null bak1 mutants was not surprising at all
given the fact that there are 13 BAK1-like receptor
kinases in Arabidopsis. Some of the BAK1 homo-
logues, especially those sharing similar expression
patterns with BRI1, might also heterodimerize with
BRI1 to mediate BR signaling and contribute to
signal specificity.
The demonstration that BAK1 participates in BR
signaling and that BAK1 physically interacts with
BRI1 in plants suggests that BAK1 might function as
a coreceptor for BRI1 in initiating BR signaling.
Such a hypothesis was supported by several lines of
genetic evidence. BAK1 overexpression can only
suppress weak bri1 mutations but fails to rescue the
mutant phenotype of a null bri1 mutant or a bri1-5
det2 double mutant with the second mutation af-
fecting BR biosynthesis (Li and others 2002), indi-
cating that the BR signaling activity of BAK1
depends on a (at least partially) functional BR11
and the presence of the plant steroids. In addition, a
null bak1 mutation could enhance a weak bri1
mutation but apparently had no significant effect on
a null bri1 mutation (Nam and Li 2002). Further-
more, overexpression of a kinase-dead BAK1 in the
weak bri1-5 mutant led to a more severe dwarf
morphology (Li and others 2002), most likely due to
dominant-negative effect of the mutated BAK1 on
the formation of the presumed signaling-active
BRI1/BAK1 dimers.
Although the genetic studies concluded that BRI1
and BAK1 could function together as a heterodimer
in mediating plant steroid signaling, biochemical
analyses of the interaction between the two recep-
tor kinases led to two different heterodimerization
models to explain how they are activated in re-
sponse to BR binding. One model closely resembles
the receptor tyrosine kinase model in which ligand
binding would trigger receptor dimerization to ac-
tivate its intrinsic kinase activity through trans-
phosphorylation, thus initiating a phosphorylation
cascade (Schlessinger 2000). The other is modeled
after the TGFb receptor, which is composed of a
homodimeric type I TGFb receptor and a homodi-
meric type II TGFb receptor. TGFb binding to the
type II receptor promotes the formation of a
heterotetramer to allow the constitutively active
type II receptor to phosphorylate and activate the
type I receptor, leading to propagation of the TGFb
signal (Attisano and Wrana 2002).
Nam and Li (2002) hypothesized that BRI1 and
BAK1 exist mainly as inactive monomers that are in
equilibrium with a small pool of active heterodimer.
BR binding promotes the formation of the BRI1/
BAK1 heterodimer, resulting in activation of both
receptor kinases through transphosphorylation and
initiation of a phosphorylation-mediated BR signa-
ling cascade. Such a model, similar to the receptor
tyrosine kinase model, is based on the biochemical
studies of the two receptor kinases expressed in
yeast cells as full-length proteins. Both BRI1 and
BAK1 were inactive when they were expressed
alone but became activated when they were coex-
pressed and interacted with each other. However,
neither BRI1 nor BAK1 was phosphorylated when
one of them was inactivated by site-directed muta-
genesis, which had no effect on their physical in-
teraction. Because yeast cells do not produce
bioactive BRs, these phosphorylation assays indi-
cated that the dimerization between BRI1 and
BAK1 is sufficient to activate the two interacting
receptor kinases but their activation requires
transphosphorylation by their partners. Consistent
with the hypothesis that a BR-binding protein is
needed for BR to bind a BRI1-containing steroid
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receptor (Li and Chory 1997), BR treatment of yeast
cells coexpressing BRI1 and BAK1 did not increase
the phosphorylation levels of the two receptor
kinases or enhance their physical interaction (Nam
and Li 2002). On the other hand, BR treatment was
known to stimulate BRI1 autophosphorylation in
plants. Additional genetic and biochemical studies
will determine whether BR activates the BRI1 kin-
ase activity by triggering the dimerization of BRI1/
BAK1 in plants and whether the BRI1/BAK1
dimerization is sufficient to activate downstream BR
signaling events.
Li and others (2002) proposed that BRI1/BAK1
interaction is more similar to the interaction be-
tween the type I and type II TGFb receptors, based
on the biochemical studies of the recombinant cy-
toplasmic domains of the two receptor kinases ex-
pressed in E. coli. Unlike the yeast-expressed full-
length proteins, the E. coli-expressed BRI1 or BAK1
fusion protein was an active kinase when tested
individually by in vitro autophosphorylation assays.
Interestingly, the phosphorylation level of BAK1
was significantly increased when it was mixed with
BRI1; however, no BRI1-stimulated BAK1 phos-
phorylation was observed if BAK1 was inactivated,
suggesting that the increased BAK1 phosphoryla-
tion was likely a result of BAK1 autophosphoryla-
tion after it was stimulated by BRI1. On the
contrary, the phosphorylation level of BRI1 re-
mained the same regardless of whether it was in-
cubated with an active or an inactive BAK1. These
results suggested a unidirectional phosphorylation
model in which an activated BRI1 phosphorylates
and activates BAK1 to initiate a BR signaling cas-
cade. The main difference between this model and
the TGFb receptor model is that BRI1 has to be ac-
tivated first by the plant steroid, whereas the type II
TGFb receptor is a constitutively active kinase. Al-
though BR treatment did increase the autophosph-
orylation level of BRI1 in plants, one has to propose
a different dimerization model, such as BRI1
homodimerization, or a completely new mechanism
to explain how BRI1 itself is activated in response to
BRs.
PROTEIN COLIGANDS FOR BR
TO BIND ITS RECEPTOR?
Although the 70AA island in the extracellular do-
main of BRI1 is critical for BR binding, such a do-
main is surrounded by LRR motifs that are best
known for mediating protein/protein interactions.
This suggests that a protein coligand might be
needed to help the plant steroid to interact with the
70AA island (Li and Chory 1997). The Arabidopsis
genome encodes several proteins that are highly
similar to animal sex steroid binding proteins, which
are thought to mediate membrane-initiated steroid
signaling (Rosner and others 1999). A recent
structural study also implicated a steroid carrier
function for Bet v 1 (Markovic–Housley and others
2003), a major birch pollen allergen that belongs to
a large family of pathogenesis-related plant proteins
(PR-10). Bet v 1 was found to contain a large Y-
shaped hydrophobic cavity that can accommodate
two molecules of deoxycholate and display a spe-
cific noncovalent interaction with BL. Arabidopsis
contains at least 40 proteins sharing the conserved
Bet v 1 structural domain, and some of them could
function as protein coligands for BL to bind to its
receptors. The involvement of putative BR-binding
proteins in BR perception was further supported by
the discovery of BRS1, a putative serine carboxyp-
eptidase, in a genetic screen for extragenic sup-
pressors of bri1-5 (Li and others 2001a). BRS1
overexpression suppressed only the extracellular
bri1 mutation but had no effect on a bri1 kinase
mutation. In addition, the phenotypic suppression
of bri1-5 by BRS1 overexpression required the
presence of active BR. Thus, BRS1 most likely
functions before the activation of a BR receptor,
possibly by converting an inactive precursor of a
putative BR-binding protein to its active form,
which can then facilitate the binding of BR to the
BRI1-containing BR receptor at the cell surface.
BIN2: A CYTOPLASMIC KINASE
NEGATIVELY REGULATING BR SIGNALING
Extensive genetic screens for Arabidopsis mutants
showing the BR-deficient phenotype but displaying
no response to BR treatment resulted in the iden-
tification of the second BRASSINOSTEROID-INSEN-
SITIVE locus, BIN2/DWARF12 (Li and others 2001b;
Choe and others 2002), which is allelic to the UCU1
gene uncovered in genetic screens for leaf devel-
opment mutants (Perez–Perez and others 2002). In
contrast to known bri1 alleles that are recessive loss-
of-function mutations, all known bin2/dwarf12/ucu1
mutants carry semidominant gain-of-function mu-
tations, including the weakest ucu1–3 mutant that
was previously thought to contain a recessive loss-
of-function mutation (Li and others 2001b; Choe
and others 2002; Perez–Perez and others 2002; Peng
and Li, unpublished data). Tetraploid analysis indi-
cated that the bin2 mutant phenotype is likely
caused by hypermorphic mutations that increase
the production or activity of the BIN2 protein. A
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root growth inhibition assay indicated that bin2
mutants are insensitive only to BR but display a
hypersensitivity to ABA and retain normal sensi-
tivity to other plant hormones, including GA, auxin,
cytokinin, and ethylene (Li and others 2001b). Like
bri1 mutants, bin2 mutants were found to accu-
mulate a higher level of BL and its biosynthetic
precursors (Choe and others 2002), suggesting that
BIN2 also participates in regulating BR homeostasis.
Taken together, these data suggest that BIN2 is an
important negative regulator in the plant steroid
signaling pathway.
BIN2 encodes a cytoplasmic Ser/Thr kinase that
displays 70% sequence identity within the catalytic
domain to those of the mammalian GSK3 and the
Drosophila SHAGGY kinases (Figure 2A) (Li and
Nam 2002), which play key roles as negative regu-
lators in a wide variety of signaling processes con-
trolling cell proliferation, cell differentiation,
cytoskeleton dynamics, and programmed cell death
(Frame and Cohen 2001). In the absence of extra-
cellular signals, GSK3 is a constitutively active
kinase that phosphorylates a variety of protein
substrates to block signal transduction through di-
rect inhibition of their biochemical activities, inter-
fering with their subcellular localization, or
promoting their degradation (Frame and Cohen
2001). In response to extracellular signals, GSK3
becomes inactivated, thus relieving its inhibitory
effect on its downstream targets.
Consistent with the genetic results suggesting
that bin2 mutants carry hypermorphic bin2 alleles,
the recombinant BIN2 kinase harboring the bin2-1
mutation was more active towards a peptide sub-
strate than the wild-type recombinant kinase (Li
and Nam 2002). In addition, it was shown that
overexpression of the wild-type BIN2 gene gave
rise to a bri1-like phenotype in transgenic plants,
with a higher BIN2 expression level leading to a
more severe dwarf phenotype. Furthermore, de-
creasing the BIN2 expression via a cosuppression
strategy could suppress a weak bri1 phenotype.
These results further supported the hypothesis that
BIN2 functions as a negative regulator in BR
signaling and implied that the inhibition of BIN2
kinase activity would constitute a key regulatory
Figure 2. Sequence alignment and structural modeling of the Arabidopsis BIN2 protein. (A) Sequence comparison
between BIN2 and the human GSK3b and Drosophila SHAGGY kinases. Black shading indicates identical amino acids,
while gray shading denotes similar residues. The TREE motif in BIN2 is underlined by the black bar and the known bin2/
dwarf12/ucu1 mutations are indicated by arrows. The Ser9 residue in human GSK3b, critical for regulation, is highlighted
by the asterisk. (B) The modeled structure of BIN2 is superimposed onto the three known GSK3 structures in the Protein
Data Bank (PDB ID: 1I09, 1GNG, and 1H8F). The structure modeling was performed at the Swiss-Model automated
knowledge-based protein-modeling server (http://www.expasy.org/swissmod/SWISS-MODEL.html). The locations of N-
terminus, C-terminus, activation loop, glycine-rich loop, the hinge that links the N-terminal b-strand domain with the C-
terminal a-helical domain, and the short a-helix containing the TREE motif are indicated.
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step after the plant steroids activate the BRI1-
containing BR receptor.
In animals, the GSK3 kinase is generally regu-
lated by two different mechanisms (Figure 3A, 3B).
One involves protein phosphorylation and the other
depends on protein/protein interaction. In the in-
sulin signaling pathway, insulin binding to its re-
ceptor triggers a phosphorylation cascade that
eventually phosphorylates GSK3 at a serine residue
near its N-terminus (Figures 2A, 3A) (Cross and
others 1995). The phosphorylated serine residue
binds to a conserved substrate-binding site, thus
preventing GSK3 from phosphorylating its down-
stream targets (Dajani and others 2001; ter Haar and
others 2001). In the Wingless pathway, GSK3
phosphorylation of b-catenin, a critical regulator for
expression of many Wnt-responsive genes, requires
the formation of a multiprotein complex that in-
cludes GSK3, b-catenin, and an adapter protein
named Axin (Ikeda and others 1998). Wnt proteins
transduce their signals through Disheveled proteins
to inhibit the GSK3 activity by the physical dis-
placement of the kinase from the GSK3/Axin/b-
catenin complex or the recruitment of FRAT/GBP, a
GSK3-binding protein, to prevent the GSK3/b-
catenin interaction (Dominguez and Green 2001),
leading to increased accumulation of b-catenin and
consequent upregulation of many proliferative
genes (Figure 3B).
It remains to be determined how BIN2 is regu-
lated by the steroid signals after the activation of
both BRI1 and BAK1 receptor kinases. BIN2 lacks
the N-terminal serine residue that is essential for the
regulation of many animal GSK3 kinases (Figure
2A). Neither BRI1 nor BAK1 was able to phos-
phorylate BIN2 and no direct physical interaction
was detected between BIN2 and these two trans-
membrane receptor kinases (Li and Nam 2002; Nam
and Li, unpublished results), suggesting that addi-
tional BR signaling protein(s) are necessary for BIN2
inhibition in response to BR. On the other hand, the
clustering of 6 out of all known 7 bin2/dwarf12/ucu1
mutations in a highly conserved 4-amino-acid Thr-
Arg-Glu-Glu (TREE) motif (Choe and others 2002;
Li and Nam 2002; Perez–Perez and others 2002)
suggests the involvement of protein–protein inter-
action and/or protein phosphorylation in BIN2
regulation (Figure 3C). Based on a recently resolved
Figure 3. Regulation of GSK3 kinases in different signaling pathways. (A) The binding of insulin to its receptor initiates a
phosphorylation cascade involving insulin receptor substrate (IRS), phosphoinositide-3-kinase (PI3K), and phosphoi-
nositide-dependent kinase 1 (PDK1), which leads to the activation of protein kinase B (PKB) that can inhibit GSK3b by
phosphorylating the Ser9 residue of the latter kinase. As a result, glycogen synthase (GS) becomes hypophosphorylated
and active. (B) In the Wnt signaling, Wnt binds to its receptor, Frizzled, leading to the activation of a cytoplasmic protein,
Disheveled. The activated Disheveled can directly interfere with the formation of the GSK3b/Axin/b-catenin destruction
complex or recruit another cytosolic protein, FRAT/GBP, which can compete with b-catenin for binding GSK3b, thus
preventing GSK3b from phosphorylating b-catenin. (C) A hypothetical model of BIN2 regulation in plants. In response to
BR signals, both BRI1 and BAK1 are activated, leading to the activation of an unknown BIN2-binding protein or an alleged
CKII that phosphorylates BIN2 at the suspected TREE motif, which can then inhibit the BIN2 kinase activity.
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crystal structure of the human GSK3b kinase, the
TREE motif is part of a short a-helix that is exposed
on the surface of the protein (Figure 2B) (Dajani
and others 2001; ter Haar and others 2001). Thus, it
is possible that this domain is critical for the inter-
action between BIN2 and a yet to be identified
GSK3-binding protein essential for BIN2 regulation.
However, the lack of mutations at other positions
within the short a-helix favors a different inhibitory
mechanism. The TREE motif is highly similar to the
consensus phosphorylation motif S/TxxD/E (D, E, S,
T, and x stand for aspartic acid, glutamic acid, ser-
ine, threonine, and any other amino acids, respec-
tively) of casein kinase II (CKII), which also prefers
acidic residues at )2 to +5 positions relative to the
phosphorylation site, with the +1 and +2 positions
being the most important ones (Meggio and Pinna
2003). The mutations of the threonine and the two
glutamate residues in TREE motif would prevent
the phosphorylation of BIN2 by such an acidic-di-
rected protein kinase, uncoupling the Arabidopsis
GSK3 kinase from a BR-activated regulatory
mechanism. We are currently investigating these
two possible mechanisms for BIN2 regulation and
searching for missing components that link the ac-
tivation of BRI1 and BAK1 to the inhibition of
BIN2.
BES1 AND BZR1: TWO NUCLEAR
COMPONENTS OF BR SIGNALING
The discovery of the cytoplasmic kinase BIN2 pro-
vided a great opportunity for identifying additional
BR signaling components. In the absence of BR
signal, BIN2 is an active kinase that would phos-
phorylate downstream targets to block the further
transduction of BR signaling in the cytosol. Using a
yeast two-hybrid method, we have identified two
novel Arabidopsis proteins (originally named BIS1
and BIS2 for BIN2 SUBSTRATE 1 and 2, respec-
tively), sharing 88% sequence identity with each
other, as potential substrates for the BIN2 GSK3
kinase (Zhao and others 2002). Interestingly, BIS1
and BIS2 were also discovered as bri1-EMS-sup-
pressor 1 (BES1) and brassinozole-resistant 1
(BZR1) in two different genetic screens for muta-
tions that suppress a weak bri1 mutant (Yin and
others 2002a) or resistant to brassinozole, a specific
BR biosynthesis inhibitor (Wang and others 2002),
respectively. In yeast, BES1 and BZR1 displayed
specific interactions with BIN2. In addition, both
proteins contain multiple copies of a conserved
GSK3 phosphorylation motif (S/TxxxS/T) and were
phosphorylated by BIN2 in vitro (He and others
2002; Yin and others 2002a; Zhao and others 2002),
apparently through a phosphorylation mechanism
distinct from those of the known animal GSK3
kinases (Zhao and others 2002; Peng and Li, un-
published results). Furthermore, the BIN2-catalyzed
phosphorylation of either BES1 or BZR1 could be
specifically inhibited by lithium (Zhao and others
2002), a known inhibitor for GSK3 kinases (Ryves
and Harwood 2002). These biochemical data
strongly suggest that BES1 and BZR1 are substrates
for the BIN2 GSK3 kinase and might play a role in
the plant steroid signaling.
The involvement of BES1 and BZR1 in BR sign-
aling was supported by several pieces of genetic
evidence. First, a Pro233Leu mutation in BES1 was
repeatedly identified as a suppressor for three dif-
ferent bri1 mutations (Yin and others 2002a; Zhao
and others 2002), while the corresponding muta-
tion, Pro234Leu, in BZR1 was able to rescue a de-
etiolation phenotype of dark-grown seedlings
caused by brassinazole treatment, a BR-deficient
mutation, or a bri1 mutation (Wang and others
2002). Second, not only the mutated BES1 and
BZR1 but also the overexpression of the wild-type
BZR1 protein was capable of suppressing the bin2
mutant phenotype (He and others 2002; Zhao and
others 2002). Third, the bes1 mutation not only
suppressed the bri1 mutant phenotype but also gave
rise to a phenotype, characterized by long and
bending petioles, curly leaves, and accelerated se-
nescence, that was previously observed in trans-
genic plants overproducing BR or BRI1 (Choe and
others 2001; Wang and others 2001), indicating that
the bes1 mutation led to a constitutive BR response,
most likely through upregulation of many BR-re-
sponsive genes (Yin and others 2002a). In contrast,
the Pro234Leu mutation in BZR1 caused a dramatic
reduction in expression of the CPD gene (Wang and
others 2002), which was known to be inhibited
specifically by BR treatment (Mathur and others
1998), and led to a weak dwarf phenotype in the
light, suggesting a role of BZR1 in regulating BR
homeostasis in addition to its function in promoting
cell elongation. Given the fact that both bes1 and
bzr1 mutations increase protein stability and nuclear
accumulation of the two proteins (Wang and others
2002; Yin and others 2002a), these genetic results
demonstrate that BES1 and BZR1 act downstream
of BRI1 and BIN2 as two positive regulators of the
BR signal transduction pathway with overlapping
yet distinct physiological functions.
Consistent with the in vitro BIN2–BES1/BZR1
phosphorylation results and the hypothesis of BR-
mediated BIN2 regulation, BR treatment resulted in
dephosphorylation of both BES1 and BZR1 proteins
306 P. Peng and J. Li
in wild-type Arabidopsis seedlings, leading to en-
hanced protein stability and increased nuclear ac-
cumulation (He and others 2002; Yin and others
2002a). In contrast, exogenous BR application had
little or no effect on the phosphorylation level or
protein stability of either BES1 or BZR1 in bin2
mutants, presumably containing mutated BIN2
proteins resistant to a BR-initiated inhibitory
mechanism. A pharmacological study with a pro-
teasome inhibitor indicated that the phosphorylated
BZR1 proteins are degraded by a proteasome-me-
diated process (He and others 2002). These bio-
chemical data strongly suggest that BZR1 and BES1
are physiological substrates for the BIN2 GSK3
kinase and that the BIN2-catalyzed phosphorylation
targets both BZR1 and BES1 for proteasome-medi-
ated protein degradation. Further genetic and bio-
chemical studies are needed to confirm that BIN2 is
the bona fide kinase that phosphorylates both BES1
and BZR1 in the absence of BR signal.
These genetic and biochemical studies revealed a
striking similarity between the plant steroid signa-
ling pathway and the Wnt signaling cascade. In the
absence of BR, BIN2 is an active kinase that would
phosphorylate BES1 and BZR1, leading to their
degradation in the cytosol to block the transduction
of BR signal into the nucleus. When the plant
steroid hormone binds the BRI1-containing BR re-
ceptor, BIN2 becomes inactivated by an unknown
regulatory mechanism, and the hypophosphorylat-
ed BES1 and BZR1 proteins move into the nucleus
to regulate gene expression (Figure 4) (He and
others 2002; Yin and others 2002a). Similarly, un-
der resting conditions, GSK3 phosphorylates b-
catenin, leading to its ubiquitin-mediated proteoly-
sis (Aberle and others 1997; Hart and others 1999).
In response to Wnt binding to a Frizzled receptor,
GSK3 is inhibited and b-catenin accumulates in the
cytosol and translocates into the nucleus to regulate
gene expression by association with other tran-
scriptional factors (Nusse 1997; Hecht and Kemler
2000). However, significant difference exists be-
tween the two pathways. First, there is no sequence
similarity between BRI1/BAK1 and Frizzled, a sev-
en-transmembrane G protein-coupled receptor
(Bhanot and others 1996), or between BES1/BZR1
and b-catenin that contains 7 armadillo (ARM) re-
peats implicated in protein–protein interactions
(Peifer and Wieschaus 1990). Second, the phos-
phorylation mechanism of BIN2 is different than
that of the GSK3 kinase, in spite of their high se-
quence homology and similar effects on their sub-
strates. In the Wnt signaling, the phosphorylation of
b-catenin by GSK3 requires a scaffold protein to
bring the kinase and the substrate together in a
multiprotein complex (Ikeda and others 1998) and a
priming phosphorylation (at the C-terminal S/T site
of the S/TxxxS/T motif by a CKII kinase) to increase
the affinity of b-catenin for the GSK3 kinase (Liu
and others 2002). By contrast, the BIN2-catalyzed
BZR1 phosphorylation is independent of either a
scaffold protein or a priming phosphorylation but
requires a direct kinase/substrate docking interac-
tion through a dedicated BIN2-binding motif at the
C-terminal end of the substrate (Zhao and others
2002; Peng and Li, unpublished data). Further
studies should determine whether the two GSK3-
mediated signaling pathways share additional
mechanistic similarities or whether the plant steroid
signaling pathway has additional unique features.
CONCLUDING REMARKS AND FUTURE
DIRECTIONS
The rapid progress over the past three years has
greatly broadened and deepened our understanding
of BR signaling mechanism. The emerging model of
BR signal transduction in plants reveals a striking
mechanistic similarity to several well-studied sign-
aling pathways in animals. A simple working model
for the plant steroid signaling involves the signal
perception/initiation by the heterodimerization of
BRI1 and BAK1 at the cell surface, signal relay
through yet to be identified component(s) that lead
to the inactivation of the BIN2 GSK3 kinase, and
subsequent stabilization and nuclear accumulation
of BES1 and BZR1 proteins that regulate an array of
BR-responsive genes (Figure 4). However, this is a
rather oversimplified linear signaling model and
more questions remain to be answered.
With respect to signal perception, it is still not
clear whether BR binds to the BRI1/BAK1 receptor
complex directly or indirectly with the aid of a se-
creted BR binding/carrier protein that might require
a BRS1-mediated proteolysis for maturation. The
genetic and biochemical characterization of several
putative Arabidopsis steroid-binding proteins men-
tioned before might provide some useful informa-
tion to answer this question. It was hypothesized
that BR would induce or stabilize BRI1/BAK1
heterodimerization, but this process has not yet
been directly demonstrated in planta. With the help
of several newly developed techniques, such as
fluorescence resonance energy transfer (FRET) and
protein fragment complementation assay (Rossi and
others 2000; Subramaniam and others 2001; Shah
and others 2002; Wehrman and others 2002), one
could monitor the BRI1/BAK1 dimerization upon
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BR binding in living plant cells and study the de-
tailed dynamics of the whole dimerization process.
Additional studies are also needed to determine
whether BAK1 is required for BR binding activity or
just functions as a signaling component of a BR
receptor.
The BRI1/BAK1 dimerization is alleged to trigger
the autophosphorylation of this receptor kinase
pair, which is critical for the activation of the re-
ceptor complex and the initiation of downstream
signaling events. Thus, identification of the BR-de-
pendent autophosphorylation sites on each receptor
kinase would help us to understand the mecha-
nism(s) of BR-induced receptor kinase activation.
Another important aspect of the receptor kinase is
the signaling output, which is essential for trans-
mitting the extracellular BR signal into the cytosol
or directly regulating membrane activity to control
cell growth. Therefore, identification of putative
substrates of BRI1 and BAK1 using the yeast two-
hybrid assay and other biochemical approaches,
such as purification of a BRI1-containing BR re-
Figure 4. A hypothetical BR signaling pathway in Arabidopsis. In the resting cell (left), BRI1 and BAK1 mainly exist as
inactive monomers that are in equilibrium with a tiny pool of BRI1/BAK1 heterodimers. The constitutively active BIN2
phosphorylates BES1 and BZR1, earmarking them for proteasome-mediated protein degradation. As a result, no BR signal
reaches the nucleus and cell elongation is inhibited. BR binding (right), presumably facilitated by a BR-binding protein
(BRBP) that might require BRS1 for proteolytic maturation, shifts the equilibrium to the formation of BRI1/BAK1 dimers,
thus activating both receptor kinases and transmitting the BR signal into the plant cell. The BR signal is subsequently
transduced by yet to be identified signaling components to inhibit the BIN2 kinase activity (see Figure 3C for two possible
regulatory mechanisms), allowing the accumulation of both BES1 and BZR1 in the nucleus to regulate gene expression,
possibly through association with other transcriptional factors that contain DNA-binding motifs. Question marks indicate
predicted yet uncharacterized components or steps.
308 P. Peng and J. Li
ceptor complex, would greatly enrich our under-
standing of the signal relay.
Another intriguing question is how BR percep-
tion is regulated throughout plant development.
Although BRI1 seems to be expressed ubiquitously
in adult plants, it is still possible that its expression
or protein activity is regulated by various endog-
enous developmental signals. Three BRI1 para-
logues were found and at least two of them were
shown to be functional BR receptors (Yin and others
2002b), but they have more restricted expression
profiles compared with BRI1 (Yu and Li, unpub-
lished data). Therefore, the competence to respond
to BR might be determined by the differential ex-
pression patterns of BRI1 and its homologues during
plant development. The hypothesized BRI1/BAK1
heterodimerization in mediating BR perception and
the fact that Arabidopsis contains 13 BAK1-like
proteins add another layer of complexity to the
regulation of BR sensitivity. Genetic studies with
mutants containing a bak1 mutation in combination
with mutations in various BAK1 homologues or
using RNA interference strategy should shed some
light on this question.
The signaling mechanism after the activation of
the BRI1/BAK1 receptor kinase pair shares similar
logic with that of the Wnt signaling pathway in
animals: The signal transmitted from the receptor
inactivates a GSK3 kinase, which leads to the dep-
hosphorylation and stabilization of nuclear signa-
ling protein(s), allowing them to accumulate in the
nucleus to control gene activities (Figure 4). Like its
animal counterparts, BIN2 plays a key role in con-
trolling the amount of the plant steroid signal that
can reach the nucleus. A better knowledge of the
biochemical mechanism of BIN2 inhibition in re-
sponse to the plant steroid signal is crucial for a clear
understanding of BR signaling. The first step to-
wards this goal is to determine at what level BIN2 is
regulated, such as protein stability, subcellular lo-
calization, or kinase activity. At the same time, ef-
fort should be made to investigate the biochemical
consequence of the known bin2 mutations. Al-
though it was reported that the bin2-1 mutation
results in a 30% increase in its kinase activity to-
ward a short peptide substrate, such a moderate
increase in the BIN2 activity might not be sufficient
to account for the severe dwarf phenotype, which
could be phenocopied only by the accumulation of
extremely high levels of the wild-type BIN2 tran-
scripts in transgenic plants (Li and Nam 2002).
Thus, understanding how these known mutations
affect the BIN2 activity could help to unlock the
secret of BIN2 regulation in BR signaling. A clear
understanding of BIN2 regulation would also re-
quire the identification of the missing components
that link the activation of the BR receptor and the
inhibition of the BIN2 kinase, which could be
identified by genetic suppressor/enhancer screen,
the yeast two-hybrid method, or purification of a
BIN2-containing multiprotein complex.
BES1 and BZR1 represent another similar feature
between BR and Wnt signaling pathways. Like b-
catenin, both proteins are regulated by similar
GSK3-initiated protein degradation processes and
are important for controlling nuclear activities
(Figure 4). Further investigation of both BES1 and
BZR1 might show whether they share additional
similar features with regard to the biochemical
mechanisms of their degradation in the cytosol and
their actions in the nucleus. In the absence of the
Wnt signal, the phosphorylated b-catenin is recog-
nized by b-TrCP, an F-box subunit of a ubiquitin
ligase complex (SCF) that ubiquitinates and targets
b-catenin for proteasome-mediated proteolysis
(Hart and others 1999). It has been shown that the
phosphorylated BZR1 is degraded by a proteasome-
mediated process (He and others 2002), but it re-
mains to be determined whether a similar F-box
protein is required for the ubiquitination of both
BES1 and BZR1 in BR signaling. In the presence of
the Wnt signal, the hypophosphorylated b-catenin
translocates into the nucleus where it interacts with
a DNA-binding protein of the TCF family of tran-
scriptional factors to control an array of Wnt target
genes (van de Wetering and others 1997; Cavallo
and others 1998). It is quite possible that BES1 and
BZR1 might also require DNA-binding proteins to
exert their effects on gene regulation because nei-
ther protein contains a recognizable DNA-binding
motif.
In comparison to the rapid progress in under-
standing how the plant steroids are transduced to
affect gene activity (the genomic effects of BR), the
nongenomic aspects of BR have largely been ig-
nored. Although it was known that gene expression
is important for many BR-elicited cellular processes,
previous studies also indicated that plant steroids
could also exert their effects on cell physiology in-
dependent of gene regulation. Both the membrane
ATPase and vacuolar ATPase were implicated in BR-
mediated cell growth (Katsumi 1991; Schumacher
and others 1999), most likely by facilitating water
uptake to generate turgor pressure to drive cell ex-
pansion. BR was also known to affect the reorgan-
ization of cortical microtubules independent of
tubulin gene expression (Mayumi and Shibaoka
1995; Catterou and others 2001), which is essential
for determining the direction of cell growth and
plant morphogenesis (Williamson 1991; Cyr and
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Palevitz 1995). Further studies are needed to reveal
how an activated BR receptor can control the ac-
tivities of the two different types of ATPases and the
nucleation/organization of the microtubules.
The discovery of additional BR signaling compo-
nents and subsequent detailed genetic and bio-
chemical studies will definitely add more
complexity and additional signaling branches to the
current simple and linear BR signaling pathway. As
an essential plant hormone that plays important
roles throughout the plant life cycle, it is also ex-
pected that some BR signaling components might
also be subject to regulations by other plant hor-
mones and certain endogenous developmental
programs. A better understanding of the BR signal
transduction pathway will not only contribute sig-
nificantly to our general knowledge of steroid hor-
mone action but will also provide important insights
into the cellular processes governing plant growth
and development.
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